Literature DB >> 23532711

IGF-1 acts as controlling switch for long-term proliferation and maintenance of EGF/FGF-responsive striatal neural stem cells.

Nor Entan Supeno1, Soumya Pati, Raisah Abdul Hadi, Abdul Rahman Izani Ghani, Zulkifli Mustafa, Jafri M Abdullah, Fauziah Mohamad Idris, Xu Han, Hasnan Jaafar.   

Abstract

BACKGROUND: Long-term maintenance of neural stem cells in vitro is crucial for their stage specific roles in neurogenesis. To have an in-depth understanding of optimal conditional microenvironmental niche for long-term maintenance of neural stem cells (NSCs), we imposed different combinatorial treatment of growth factors to EGF/FGF-responsive cells. We hypothesized, that IGF-1-treatment can provide an optimal niche for long-term maintenance and proliferation of EGF/FGF-responsive NSCs.
OBJECTIVE: This study was performed to investigate the cellular morphology and growth of rat embryonic striatal tissue derived-NSCs in long-term culture under the influence of different combinatorial effects of certain growth factors, such as EGF, bFGF, LIF and IGF-1.
METHODS: The NSCs were harvested and cultured from striatal tissue of 18 days old rat embryos. We have generated neurospheres from these NSCs and cultured them till passage 7 (28 days in vitro) under four different conditional microenvironments: (A) without growth factor, (B) EGF/bFGF, (C) EGF/bFGF/LIF, (D) EGF/bFGF/IGF-1 and (E) EGF/bFGF/LIF/IGF-1. Isolated NSCs were characterised by Immunoflouroscence for nestin expression. The cell growth and proliferation was evaluated at different time intervals (P1, P3, P5 & P7), assessing the metabolic activity based cell proliferation. Apoptosis was studied in each of these groups by In situ cell death assay.
RESULTS: Our results demonstrated certain important findings relevant to long-term culture and maintenance of striatal NSC-derived neurospheres. This suggested that IGF-1 can induce enhanced cell proliferation during early stages of neurogenesis, impose long-term maintenance (up to passage 7) to cultured NSCs and enhance survival efficiency in vitro, in the presence of EGF and FGF.
CONCLUSIONS: Our findings support the hypothesis that the enforcement of IGF-1 treatment to the EGF/FGF-responsive NSCs, can lead to enhanced cell proliferation during early stages of neurogenesis, and an extended life span in vitro. This information will be beneficial for improving future therapeutic implication of NSCs, by addressing improved in vitro production of NSCs.

Entities:  

Keywords:  EGF; IGF-1.; LIF; bFGF; neural stem cells; neurospheres; proliferative activity

Mesh:

Substances:

Year:  2013        PMID: 23532711      PMCID: PMC3607237          DOI: 10.7150/ijms.5325

Source DB:  PubMed          Journal:  Int J Med Sci        ISSN: 1449-1907            Impact factor:   3.738


Introduction

Current stem cell based regenerative therapies include a broad range of adult stem cell sources like; neural stem cells (NSCs) and mesenchymal stem cells (MSCs) in neural repair 30. In recent years, there has been growing interest in the use of neural stem cells (NSCs) as a novel approach for the treatment of neurodegenerative diseases. NSCs have gained popularity as a potential cell therapy agent due to their ability to mitigate neurodegenerative diseases by replacing impaired tissues. NSCs are characterised as undifferentiated cells with the capacity to self-renew (while maintaining an undifferentiated state) that can give rise to all neural lineages: including neurons, astrocytes and oligodendrocytes 3, 8, 32, 36, 41. The major pitfall that has been encountered till now in growing NSCs is their long-term maintenance in vitro, due to unavailability of optimal guidance cues for their microenvironmental niche. Studies in recent past have demonstrated certain neurotrophins like; Insulin growth factor (IGF-1), Fibroblast Growth Factor (FGF), Epidermal Growth Factor (EGF) and Leukaemia Inhibitory Factor (LIF) can induce recovery of post-ischemic brain injury in rats 13, 19, 24, 28, 34. Among these factors, recruitment of the dual colonial growth factors; such as FGF-2 and EGF was found to be essential for growth and survival of E14-E20 embryonic striatal stem cells (ESSCs) 14. Previous studies have also shown that Insulin Growth Factor-1 (IGF-1) can affect early embryonic development in culture by increasing the total cell number 11, 18. Interestingly, a group of evidences also suggested that IGF-1 plays a controlling factor for the above factors strictly regulating their phenotypic abilities 2. And LIF could increase proliferation and telomerase expression of EGF-responsive human fetal cortical neural progenitors in vitro, but with decreased neurogenesis 38. Based on these experimental evidences, we designed an experimental strategy to investigate the effect of IGF-1 and LIF on long-term maintenance of EGF/FGF- responsive embryonic striatal neural precursors from E18 rat embryos, as both EGF/FGF are essential for in vitro culture of NSCs. Our findings have suggested that administration of IGF-1 to EGF/FGF-responsive striatal progenitors can enhance proliferating ability of these cells in long-term culture in vitro. This combinatorial microenvironment will be extremely beneficial for future NSC-based therapies in neuro-regenerative application.

Material and methods

Breeding of Sprague-Dawley (SD) rat

Monogamous pairs of male (8-10 weeks old) and female SD rats (10-14 weeks old) were obtained from the Animal House Unit (LARAS, USM). A healthy SD male rat was housed individually in a new cage for one to two hours to ensure proper adaptation, prior to introduction of a healthy female SD rat into the same cage. The animals were left overnight, following a stable social interaction (non-fighting mode), and the female rat was checked for pregnancy the next morning using the vaginal swab method 12. The caging and handling of the rats were carried out in accordance with proper laboratory practice criteria as defined by the Animal House Unit (LARAS, USM), and all experimentation was approved by the Animal Ethics Committee (Number of approval: USM/Animal Ethics Approval/2007/30/097).

Isolation of embryonic rat striatal tissue

The isolation of embryonic striatal tissue was carried out as previously described 1, 10, 15, 22. Pregnant SD rats with embryos aged E18 days of gestation were selected for the experiment. The pregnant rat was anesthetised using a mixture of ketamine/xylazine at dosages ranging from 40 to 87 mg/kg for ketamine and 5 to 13 mg/kg for xylazine. The peritoneal area was cleaned with hibiscrub, shaved, wiped with 70% alcohol and finally wiped with iodine for aseptic purposes. The rat was then covered with fenestrated sterile gauze, except for three inches of the peritoneal midline, which was left exposed. A midline incision was performed on the skin as the uterus and the embryos were aseptically removed. The embryos were harvested from their individual sacs beginning at the distal end of the uterine horn. The pregnancy stage of the rats was estimated by measuring the crown-rump length (CRL) of the embryos as previously described 10. Each embryo was immersed in 70% ethanol for one second to reduce bleeding and to avoid sources of contamination from the blood. The embryo was then placed into a petri dish containing cold 6% glucose in PBS (PBSg) to keep the brain tissue moist. The embryonic striatal tissue was isolated as previously described 8. Using a stereoscopic dissecting microscope, a striatal surface region was anatomically identified by its characteristic blotchy appearance. The striatal tissues were then isolated and pooled into a 50 mL falcon tube containing 15 mL of PBSg, which was followed by the culturing procedures. The pooled striatal tissues were minced into small sections and 1% penicillin/streptomycin were added to prevent contamination.

Culturing of NSCs

The methods used to culture the embryonic striatal tissue were performed as previously described 5 with some modifications. Briefly, the pooled striatal tissue in phosphate buffer saline with glucose, PBSg was rinsed in the presence of 1% penicillin/streptomycin. The tissues were digested by adding 1% detachin for 10 to 20 minutes in a 37ºC water bath. The cells were then centrifuged at 1600 rpm for 5 minutes followed by the pellets were re-suspended in 1 mL of serum-free media. Single-cell suspensions were obtained using mechanical dissociation. The mixture was triturated using a 23G syringe needle and filtered through a 40 µm cell strainer to remove debris and non-dissociated cells. Cells were counted using trypan blue to verify cell viability. The cells were then grown using the Neurocult NS-A Proliferation Media kit for rat (StemCell Technologies, Inc, USA, C/N: 05771). In accordance with the study design, EGF (20 ng/mL), bFGF (20 ng/mL), LIF (10 ng/mL), IGF-1 (100 ng/mL) and/or heparin (5 µg/mL) were added to the media. In this study, the NSCs were cultured in five experimental groups: group A (without growth factor), group B (EGF/bFGF), group C (EGF/bFGF/LIF), group D (EGF/bFGF/IGF-1) and group E (EGF/bFGF/LIF/IGF-1). The cells were cultured in T-25 cm2 culture flasks at a cell density of 10-15 cells/µL, and the growth factors were added every two to three days. Neurospheres usually formed after three to four days of in vitro culturing. The culture flasks were gently agitated several times a day to prevent adherence of the neurospheres to the flask wall, which would result in cell differentiation. The culture flasks were maintained and incubated at temperature of 37ºC using 5% CO2 incubator.

Passaging of NSCs

Following confluency, the neurospheres were passaged into different flasks in order to promote expansion of cell number. The neurospheres were passaged every 4th day in vitro, once they reach the size of 150 to 200 µm in diameter, as they can be easily dissociated into single cells at this stage. These neurospheres were then centrifuged at 400 rpm for 5 minutes, followed by 1600 rpm for 6 minutes to separate the cells from media 40. The supernatant was gently removed, and the cell pellets were then incubated in 1% detachin for 10 minutes at 37ºC. After incubation, the neurospheres were triturated first using a pasteur pipette, then using a 1 mL pipette tip and finally with a 23G syringe needle, 10 to 15 times for each needle, as previously described 17. These cells were again centrifuged at 1600 rpm for 5 minutes, to discard the supernatants. Finally, the pellet containing single cells were re-seeded in complete medium containing growth factors.

Cellular morphology of the NSCs

The cellular morphology of the NSCs was examined during four different passages: P1, P3, P5 and P7 (each passage was performed at every four days in vitro). We compared the cellular morphology of the NSCs and examined the sizes of the neurospheres from the five different growth factor groups. In this way, we determined the optimal combination of growth factors with respect to NSC cell growth and cellular morphology. Cellular morphology was assessed by observation under an inverted microscope.

Immunocytochemical staining

Immunocytochemical (ICC) staining was performed to ensure that the isolated cells were indeed neural stem cells. In this study, adult rat hippocampal neural stem cells were used as a positive control (Chemicon International, Inc, USA, C/N: SCR022). Characterisation of the NSCs was performed as follows: Neurospheres were placed into 8-well chamber slides. The cells were then fixed using 4% paraformaldehyde in 1X PBS and incubated for 30 to 40 minutes at RT. After incubation, the fixative was carefully removed using aspiration, and the cells were washed three times (5 to 10 minutes each) with 1X PBS. After washing, the cells were permeabilised with 0.3% Triton X-100. Next, cells were washed with a blocking solution of 5% normal donkey serum (Chemicon International, Inc, USA, C/N: S30-100ML) for at least two hours at RT or overnight at 4ºC. The cells were then incubated overnight at 4ºC with the primary antibody mouse anti-nestin (monoclonal, 1:200) (Chemicon International, Inc, USA, C/N: 2003602) 24, 30. Negative controls were treated identically except for the addition of the primary antibody. The next day, cells were washed twice with 1X PBS and twice with blocking solution. After the last wash step, the cells were left in blocking solution for at least 30 minutes. Donkey anti-mouse IgG conjugated to Cy3 (1:250 or 1:500) (Chemicon International, Inc, USA, C/N: AP192C) was used as the secondary antibody, and the cells were incubated with this secondary antibody for two hours at RT. After incubation, the cells were washed for three to five times using 1X PBS. Cell nuclei were then stained with acridine orange at a working concentration of 1:500. Finally, the sections were mounted on glass chamber slides using anti-fading UltraCruzTM mounting medium to minimise photo-bleaching after prolonged exposure to a high-intensity light source. The fixed cells were then visualised using a Pascal 5 confocal microscope (Carl Zeiss, Germany).

Proliferation study

Proliferation studies were performed using the CellTiter 96® Aqueous One Solution Cell Proliferation Assay (Promega Corporation, USA, C/N: G3580), which uses a novel tetrazolium compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt; MTS (a)] and a chemically stable electron coupling reagent (phenazine ethosulfate; PES) to form a stable “One Solution”. Bioreduction of MTS to colored formazan was read at 490nm, to evaluate metabolically active cells, and the level of cytotoxicity in cutured cells. Our experimental strategy involved five groups of combinatorial growth factor conditions (group A:without growth factor, group B: EGF/bFGF, group C: EGF/bFGF/LIF, group D: EGF/bFGF/IGF-1 and group E: EGF/bFGF/LIF/IGF-1). NSCs were grown at a starting density of 1X103 cells per well of 96-well culture plate, with 5 replicates for each group. Spectrophotometric recordings were obtained from each group of cells at 0, 24, 48, 72 and 96 hours following the exact procedure suggested by instruction manual, to evaluate the increment in cell proliferation.

In situ cell death detection (TUNEL)

To demonstrate the effect of different neurotrophins on NSCs undergoing apoptosis, we used a terminal dUTP nick-end labelling (TUNEL) assay. At 12 days in vitro, neurospheres were triturated into single cells and plated on poly-L-lysine-coated 8-well chamber slides (BD BioCoat, USA) at a concentration of 50,000 per ml per well and incubated for an additional 6 h at 37°C in a 5% CO2 incubator. The apoptotic cells were labelled according to the instructions of the in situ Cell Death Detection Kit (Roche, Penzberg, Germany). The TUNEL-labelled cells were further counter-stained and mounted using Ultra Cruz mounting dye containing DAPI (Santa Cruz). The number of TUNELNSCs was detected by Zeiss fluorescence microscopy and normalised to DAPI-stained cells.

Statistical analysis

Two-way anova was performed among cultured NSCs at P1, P3, P5 and P7 for different time intervals; such as 24hrs, 48hrs, 72hrs and 96hrs, to elucidate the changes in cell proliferation. The NSCs from each group were also compared using pair wise comparisons using Tukey's HSD test (Tukey's honestly significant difference test). Based on this analysis, we concluded that time and cell types derived from each group, led to a significant change in values. Consequently, we also considered these main factors separately to explore how the values changed in response to each of these two factors. To achieve this goal, we separated our comparisons at each time point. Because time interval was fixed, we applied Tukey's HSD test (Tukey's honestly significant difference test) to compare the means of NSCs from two different conditions. The result was represented by a colored matrix. Each box in this matrix represented a paired comparison, and the matrix is colour coded by P-values ranging from 0 to 1 showing red as low and blue as high. The P-values for the paired comparisons were recorded for each group, to clearly delineate the significantly different pairs in the matrix. All data are expressed as the mean ± SD. P-values <0.05 were considered statistically significant in all experiments.

Results

Cellular morphological analysis

The cellular morphology of striatum-derived progenitors were analysed by microscopy for changes in appearance during each passage (P1, P3, P5 and P7). We observed that new floating spheres were formed as a consequence of cell proliferation. These cellular aggregates or neurospheres were identified as both well-defined spherical cell clusters as well as more irregular cell clusters, as shown in Figure 1. Cilia were also present on the surface or outer edges of some of the neurospheres, indicating that the neurospheres were in a healthy condition, as previously reported 5, 18.
Figure 1

Cellular morphological analysis of neurospheres. (A) Neurospheres vary in shape; some are well-formed spheres, whereas others are irregular cell clusters. (B) The P1 of NSCs cultures contained cell debris. (C) By P3, neurosphere cultures contained less debris compared with P1. The neurospheres adopted spherical shapes with bright surfaces. (D) Healthy neurospheres are composed of many individual cells and possess small cilia that are apparent on the outer edge. All images were viewed at 100X magnification using an inverted microscope.

Immunocytochemical staining of NSCs

NSCs are represented by expression of Nestin; a most prominent signature associated with neural precursors of central nervous system 32. Immunocytochemical staining of NSCs was performed to characterise the isolated cell population. Our findings show that neurosphere isolates from all the experimental groups were positively stained for nestin at P1, as shown in Figure 2. The isolated neurospheres reached confluency between 3 to 5 days in vitro. Nestin characterization was performed for neurospheres at P1 and P3 stages. The results displayed that neurospheres at P3 (Figure 2) stained positive for nestin and appeared as well-defined spheres compared to P1. Our results supported a previous report, which suggested that NSCs during early passage (e.g., P1) contain numerous dead cells and cell debris that can be eliminated by further passaging 16.
Figure 2

Immunocytochemical staining of embryonic striatal stem cells in culture. Results show that neurospheres were positively stained for nestin (red). (A) Phase-contrast image of a neurosphere. (B) Negative control. (C) Adult rat hippocampal neural stem cells as positive control. (D) Neurosphere at P1. (E) Neurosphere at P3. Neurospheres were viewed at 200X magnification using a Pascal 5 confocal microscope (Carl Zeiss, Germany).

Long term maintenance of neurospheres in vitro

In this study, we have evaluated the relative sizes of NSCs from the four different combinatorial groups of growth factors: e.g., group A (without growth factor), group B (EGF/bFGF), group C (EGF/bFGF/LIF), group D (EGF/bFGF/IGF-1) and group E (EGF/bFGF/LIF/IGF-1) at four passages (P1, P3, P5 and P7). These neurospheres were able to remain as undifferentiated spheres till P7. Additionally, the amount of debris was reduced following continuous passaging in all of the groups. We also found that the NSC spheres grew to different sizes in the different growth factor groups. For example, our results show that neurospheres from group D were relatively larger and mature than those from the other groups during all of the examined passages (Figure 3). On the other hand, group A had the smallest spheres during all passages. Interestingly, group D neurospheres from P3 to P7 showed the greatest confluency only three days after subculture, in contrast with the other groups, but with a much denser core as compared to other groups.
Figure 3

The NSCs at P1 until P7 shows different sizes of neurospheres grown in different groups of growth factors. Group A (without growth factor); Group B (EGF/bFGF); Group C (EGF/bFGF/LIF); Group D (EGF/bFGF/IGF-1) and group E (EGF/bFGF/LIF/IGF-1). Group D had the largest in size of neurospheres. Viewed at 100X magnification using an inverted microscope.

Effect of IGF-1 on proliferation and survival of NSCs

To understand the role of long term proliferation and survival efficiency of neurospheres in vitro, we have grown EGF/FGF responsive NSCs alone and under the influence of different combinations of growth factors until passage 7. To elucidate the effects of these factors on proliferation of NSCs, we have investigated the changes in their metabolic viability at different time intervals (24 hrs, 48 hrs, 72 hrs and 96 hrs) till P7, using a spectrophotometric based cell proliferation assay in vitro. This assay demonstrated a visual representation of changes in the number of metabolically viable cells among different treatment groups, by evaluating the metabolic activity of cellular enzymes that converted the tetrazolium dye MTS ([3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt) into formazan product. So the amount of formazan production not only indicated both growth and proliferation of NSCs, also showed the effect of growth factor treatments on NSC cytotoxicity. Our results suggested three important findings; 1) IGF-1 enhanced proliferation of neural stem cells during the early stages of neurogenesis in vitro (Fig. 4A); 2) IGF-1-I treated EGF/FGF responsive population showed higher survival efficiency as shown by less tunnel positive cells (Fig. 4B); 3) LIF treatment couldn't rescue the EGF/FGF responsive cells even in the presence of IGF-1 (Fig. 4A).
Figure 4

Long-term Proliferation and survival of ESSCs: Embryonic neural stem cells were cultured under different cocktails of growth factors (n=5) and change in proliferation was studied at P1, P3, P5 and P7 days of passage using in vitro cell proliferation assay (A).Two-way anova analysis was performed for all the above cell populations to study the significance changes in the rate of proliferation. The data was represented as optical density (OD) at 540nm in mean ± SD. P-value <0.05 was considered as significant. Survival efficiency was also evaluated for ESSCs from all groups by TUNEL assay, and staining was visualized in fluorescent microscopy at 20X magnification. Panel B demonstrated TUNEL/DAPI NSCs at P3 from different niche conditions (B). Data only shown for group C and group D derived NSCs. The TUNEL/DAPI NSCs from control group A cultured without any growth factor.

To validate these data we have also performed a two-way ANOVA analysis among different groups of NSCs, which demonstrated that IGF-1 treatment could lead to a stable increase in cell proliferation at almost all time points (24 hrs, 48 hrs, 72 hrs and 96 hrs) (n=5,* P ≤0.05) during the early stages of development (Fig.4A). To further compare the substantial changes in proliferation of IGF-instructed NSCs with other groups at different time intervals (P1, P3, P5 and P7), we have also performed Pair wise comparative analysis (Fig.5). These results also explained the possible significance of growth factor treatments on long-term growth profile of NSCs in vitro.
Figure 5

Pair wise comparative analysis of long-term growth profile of ESSCs at different time intervals: Pair wise comparison was analyzed in detail, among NSCs cultured under the influence of different growth factor conditions at P1, P3, P5 and P7 passages using Tukey's HSD (Tukey's honestly significant difference test). The data was represented as mean ± SD and statistical significance was based on P-value <0.05.

Our data also demonstrated an interesting observation, which suggested that addition of LIF to the culture was detrimental to the early stage of proliferation of NSCs, as shown by reduced proliferation (Fig.4A). And even the treatment of IGF-1 could not rescue the proliferation of NSCs (Fig.4A).

Discussion

Accumulating evidence from adult neurogenesis-based studies has shown that synergistic treatment with FGF-2 and EGF increases progenitor proliferation in the sub-ventricular zone (SVZ) of global ischemia and enhances post-ischemic memory formation and retention 4, 30. Both EGF and FGF-2 are co-localised during embryonic developmental stages and comprise a synergistic signalling pathway in neural stem cells, which significantly contributes to neurogenesis. It was also noteworthy those IGF-1 acts as a controlling switch for both of these “colonial” growth factors, and modulates their action during neurogenesis 2. Our study has strongly corroborated the above information, as IGF-1 treatment could drastically enhance early stage proliferation of EGF/FGF-responsive neural stem cells in vitro (Fig. 4A). Although the enhancement in proliferation was maintained till P7, the change was most evident in the early stages at P1 and P3 (Fig. 4A). Earlier findings have shown that IGF-1 acts via the extracellular signal-related kinase (ERK) /mitogen-activated protein kinase (MAPK) pathway, activating cAMP response element-binding protein (CREB) and leading to enhanced mitogenesis 22. Our data has indicated a positive regulatory role of IGF-1, as demonstrated by the consistency in enhancement proliferation of IGF-1-treated NSCs during the early stages of neurogenesis. Our results also presented another interesting piece of information, which suggested that, treatment of LIF can negatively attenuate early stage proliferation of EGF/FGF-responsive NSCs, and could not increase the survival efficiency of these cells, even in presence of IGF-1 (Fig. 4A). These results led us to hypothesize that 1) LIF could not support the proliferation of NSCs, and 2) it might regulate the early-stage maturation of these cells. Our hypothesis directly corroborates some earlier published reports, which suggested, LIF treatment could not enhance the survival of cortical precursor cells isolated from later rat embryos (beyond embryonic day 16, E16) and might also regulate the number of neural precursors in the stem cell pool by preventing the emergence of more differentiated cell types via the activation of the transcription factor STAT3 12,27. Thus our results explained, LIF treatment in NSCs could not help recovery of NSCs isolated from E18 embryos and also might attenuate the maturation of NSCs to maintain the self-renewing pool of NSCs. Based on these observations it is important to highlight that, an optimal microenvironmental niche containing growth factors like IGF-1+EGF+FGF can be important in long-term maintenance and growth of embryonic neural stem cells in vitro.

Conclusion

We hereby conclude that IGF-1 can be the important guidance cue for EGF/FGF-responsive neural stem cells in vitro, and play crucial role in long-term proliferation and maintenance of neural stem cells.
  34 in total

1.  Defining the actual sensitivity and specificity of the neurosphere assay in stem cell biology.

Authors:  Ilyas Singec; Rolf Knoth; Ralf P Meyer; Jaroslaw Maciaczyk; Benedikt Volk; Guido Nikkhah; Michael Frotscher; Evan Y Snyder
Journal:  Nat Methods       Date:  2006-10       Impact factor: 28.547

2.  Differential centrifugation in culture and differentiation of rat neural stem cells.

Authors:  Sheng Ye; Zhi-peng Su; Jing Zhang; Xu Qian; Qi-chuan Zhuge; Yan-jun Zeng
Journal:  Cell Mol Neurobiol       Date:  2007-09-01       Impact factor: 5.046

Review 3.  Stem and progenitor cells for neurological repair: minor issues, major hurdles, and exciting opportunities for paracrine-based therapeutics.

Authors:  Issei S Shimada; Jeffrey L Spees
Journal:  J Cell Biochem       Date:  2011-02       Impact factor: 4.429

4.  Differentiation of rat striatal embryonic stem cells in vitro: monolayer culture vs. three-dimensional coculture with differentiated brain cells.

Authors:  B Pardo; P Honegger
Journal:  J Neurosci Res       Date:  2000-02-15       Impact factor: 4.164

5.  Membrane properties of rat embryonic multipotent neural stem cells.

Authors:  Jingli Cai; Aiwu Cheng; Yongquan Luo; Chengbiao Lu; Mark P Mattson; Mahendra S Rao; Katsutoshi Furukawa
Journal:  J Neurochem       Date:  2004-01       Impact factor: 5.372

6.  Effect of single growth factor and growth factor combinations on differentiation of neural stem cells.

Authors:  Kyung-Chul Choi; Do-Sung Yoo; Kyung-Sock Cho; Pil-Woo Huh; Dal-Soo Kim; Chun-Kun Park
Journal:  J Korean Neurosurg Soc       Date:  2008-12-31

7.  Leukemia inhibitory factor inhibits neuronal terminal differentiation through STAT3 activation.

Authors:  Cheil Moon; Joo-Yeon Yoo; Valéry Matarazzo; Young Kwan Sung; Esther J Kim; Gabriele V Ronnett
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

8.  Characterization of proliferation and differentiation of EGF-responsive striatal and septal precursor cells.

Authors:  Lazara Castillo; Lisis Martínez; Elizabeth Grygar; Birgit Hutter-Paier
Journal:  Int J Dev Neurosci       Date:  2003-02       Impact factor: 2.457

9.  Inhibitory effect of IGF-I on induced apoptosis in mouse preimplantation embryos cultured in vitro.

Authors:  Dusan Fabian; Gabika Il'ková; Pavol Rehák; Sona Czikková; Vladimír Baran; Juraj Koppel
Journal:  Theriogenology       Date:  2004-02       Impact factor: 2.740

10.  Intranasal administration of IGF-1 attenuates hypoxic-ischemic brain injury in neonatal rats.

Authors:  Shuying Lin; Lir-Wan Fan; Philip G Rhodes; Zhengwei Cai
Journal:  Exp Neurol       Date:  2009-03-28       Impact factor: 5.330

View more
  21 in total

Review 1.  Dental pulp stem cells and osteogenesis: an update.

Authors:  Ibrahim Mortada; Rola Mortada
Journal:  Cytotechnology       Date:  2018-06-25       Impact factor: 2.058

2.  Rapid Serum-Free Isolation of Oligodendrocyte Progenitor Cells from Adult Rat Spinal Cord.

Authors:  John Bianco; Dario Carradori; Ronald Deumens; Anne des Rieux
Journal:  Stem Cell Rev Rep       Date:  2017-08       Impact factor: 5.739

3.  Isolation and Expansion of Adult Canine Hippocampal Neural Precursors.

Authors:  Thomas Duncan; Aileen Lowe; Marshall A Dalton; Michael Valenzuela
Journal:  J Vis Exp       Date:  2016-11-29       Impact factor: 1.355

4.  Induced neural progenitor cells abundantly secrete extracellular vesicles and promote the proliferation of neural progenitors via extracellular signal-regulated kinase pathways.

Authors:  Yizhao Ma; Kaizhe Wang; Jiabin Pan; Zhaohuan Fan; Changhai Tian; Xiaobei Deng; Kangmu Ma; Xiaohuan Xia; Yunlong Huang; Jialin C Zheng
Journal:  Neurobiol Dis       Date:  2018-12-04       Impact factor: 5.996

5.  Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.

Authors:  Keren Regev; Brian C Healy; Fariha Khalid; Anu Paul; Renxin Chu; Shahamat Tauhid; Subhash Tummala; Camilo Diaz-Cruz; Radhika Raheja; Maria A Mazzola; Felipe von Glehn; Pia Kivisakk; Sheena L Dupuy; Gloria Kim; Tanuja Chitnis; Howard L Weiner; Roopali Gandhi; Rohit Bakshi
Journal:  JAMA Neurol       Date:  2017-03-01       Impact factor: 18.302

6.  Activation of IGF-1/GLP-1 Signalling via 4-Hydroxyisoleucine Prevents Motor Neuron Impairments in Experimental ALS-Rats Exposed to Methylmercury-Induced Neurotoxicity.

Authors:  Ambika Shandilya; Sidharth Mehan; Sumit Kumar; Pranshul Sethi; Acharan S Narula; Abdulrahman Alshammari; Metab Alharbi; Abdullah F Alasmari
Journal:  Molecules       Date:  2022-06-16       Impact factor: 4.927

7.  The regulatory mechanism of neurogenesis by IGF-1 in adult mice.

Authors:  Honghua Yuan; Renjin Chen; Lianlian Wu; Quangang Chen; Ankang Hu; Tengye Zhang; Zhenzhen Wang; Xiaorong Zhu
Journal:  Mol Neurobiol       Date:  2014-04-29       Impact factor: 5.590

8.  Methamphetamine induces low levels of neurogenesis in striatal neuron subpopulations and differential motor performance.

Authors:  I K Tulloch; L Afanador; L Baker; D Ordonez; H Payne; I Mexhitaj; E Olivares; A Chowdhury; J A Angulo
Journal:  Neurotox Res       Date:  2014-02-19       Impact factor: 3.911

9.  MicroRNA Expression Profile of Neural Progenitor-Like Cells Derived from Rat Bone Marrow Mesenchymal Stem Cells under the Influence of IGF-1, bFGF and EGF.

Authors:  Tee Jong Huat; Amir Ali Khan; Jafri Malin Abdullah; Fauziah Mohamad Idris; Hasnan Jaafar
Journal:  Int J Mol Sci       Date:  2015-04-29       Impact factor: 5.923

10.  IGF-1 enhances cell proliferation and survival during early differentiation of mesenchymal stem cells to neural progenitor-like cells.

Authors:  Tee Jong Huat; Amir Ali Khan; Soumya Pati; Zulkifli Mustafa; Jafri Malin Abdullah; Hasnan Jaafar
Journal:  BMC Neurosci       Date:  2014-07-22       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.